In the chronic setting, comprehensive management of obesity should combine caloric restriction, increased physical activity, and, when indicated, pharmacologic or surgical interventions
Beyond these principal sites of GLP-1R action, lower-level receptor expression has been documented in several additional tissues, including the heart, kidney, lungs, and testis (Pyke et al., 2014
For patients with type 2 diabetes and chronic kidney disease, the FLOW data support semaglutide 1.0 mg
Wegovys cardiovascular evidence The SELECT trial, published in The New England Journal of Medicine and The Lancet , followed more than 17,000 adults with overweight or obesity and established cardiovascular disease
Among the emerging concepts is the use of exosomes, microscopic components naturally released
In chemotherapy-sensitive patients, Keap1 (Kelch-like ECH-associated protein 1) binds to NRF2 and mediates NRF2 ubiquitination via the Cul3-E3 ligase complex, promoting its degradation and maintaining NRF2 at low levels [32]